CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells

Background/Aims: Metastasis is the major cause of death in patients with osteosarcoma. There is an urgent need to identify molecular markers that promote metastasis. Cluster of differentiation 44 is a receptor for hyaluronic acid (HA) and HA-binding has been proven to participate in various biologic...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tang Liu, Zuyun Yan, Yong Liu, Edwin Choy, Francis J. Hornicek, Henry Mankin, Zhenfeng Duan
Format: Artigo
Langue:Inglês
Publié: Cell Physiol Biochem Press GmbH & Co KG 2018-04-01
Collection:Cellular Physiology and Biochemistry
Sujets:
Osteosarcoma
CRISPR-Cas9
Meta-analysis
CD44
Metastases
Gene therapy
Accès en ligne:https://www.karger.com/Article/FullText/489072
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires